Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy - Top-Institutions - MDSpire

Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy

  • By

  • B Siontis

  • S Kumar

  • A Dispenzieri

  • M T Drake

  • M Q Lacy

  • F Buadi

  • D Dingli

  • P Kapoor

  • W Gonsalves

  • M A Gertz

  • S V Rajkumar

  • October 23, 2015

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Nuclear Medicine
    • Radiology

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Radiology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Nuclear Medicine

  • #4

    University of Heidelberg
    University of Heidelberg

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Hematology
    • Oncology
    • Nuclear Medicine

  • #5

    University of Arkansas for Medical Sciences
    University of Arkansas for Medical Sciences

    Little Rock, AR

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy

  • by B Siontis, S Kumar, A Dispenzieri, M T Drake, M Q Lacy, F Buadi, D Dingli, P Kapoor, W Gonsalves, M A Gertz, S V Rajkumar

  • October 23, 2015

Related Content

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic

Combination of Lisaftoclax, Ixazomib, and Dexamethasone for Maintenance Therapy Following CAR-T in Patients with Transplant-Ineligible Relapsed/Refractory Ultra-High-Risk Multiple Myeloma: A Review of Two Cases and Relevant Literature

Romiplostim N01 Enhances Platelet Recovery in Autologous Stem Cell Transplantation with Non-Cryopreserved Peripheral Blood Stem Cells for Plasma Cell Disorders